Login to Your Account

Financings Roundup

Stem Cell Tech Firm VistaGen Goes Public via Reverse Merger

By Jennifer Boggs

Wednesday, May 18, 2011
The latest firm to opt for a reverse merger rather than the more traditional initial public offering, VistaGen Therapeutics Inc. inked a deal to merge with Excaliber Enterprises Ltd., a public shell listed on the Over-the-Counter Bulletin Board.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription